ticlopidine has been researched along with Acute Onset Aura Migraine in 3 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt." | 7.73 | Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005) |
| "Transcatheter closure of an atrial septal defect using the Amplatzer septal occluder is a current treatment option in Japan, but is occasionally associated with transient exacerbation or new onset migraine." | 5.34 | Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report. ( Hatakeyama, K; Kobayashi, T; Soda, W; Tomita, H, 2007) |
| "The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt." | 3.73 | Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005) |
| "Transcatheter closure of an atrial septal defect using the Amplatzer septal occluder is a current treatment option in Japan, but is occasionally associated with transient exacerbation or new onset migraine." | 1.34 | Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report. ( Hatakeyama, K; Kobayashi, T; Soda, W; Tomita, H, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spencer, BT | 1 |
| Qureshi, Y | 1 |
| Sommer, RJ | 1 |
| Wilmshurst, PT | 1 |
| Nightingale, S | 1 |
| Walsh, KP | 1 |
| Morrison, WL | 1 |
| Tomita, H | 1 |
| Hatakeyama, K | 1 |
| Soda, W | 1 |
| Kobayashi, T | 1 |
1 trial available for ticlopidine and Acute Onset Aura Migraine
| Article | Year |
|---|---|
A retrospective review of clopidogrel as primary therapy for migraineurs with right to left shunt lesions.
Topics: Adolescent; Adult; Clopidogrel; Female; Foramen Ovale, Patent; Humans; Middle Aged; Migraine with Au | 2014 |
2 other studies available for ticlopidine and Acute Onset Aura Migraine
| Article | Year |
|---|---|
Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects.
Topics: Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Drug Therapy, Combination; Female; Heart Septa | 2005 |
Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report.
Topics: Adolescent; Cardiac Catheterization; Female; Heart Septal Defects, Atrial; Humans; Migraine with Aur | 2007 |